Contingency Management for Alcohol Use Disorders

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol Use Disorder Alcohol-Related Disorders Alcoholism Chemically-Induced Disorders Contingency Management Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Farrell Treatment Center, New Britain, Connecticut, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 18 years or older
current diagnosis of alcohol use disorder and self report of recent alcohol use
pass an informed consent quiz
agree to wear a SCRAMx monitor for 12 weeks
have a standard SCRAMx compatible phone line in their home or agree to attend the clinic weekly for brief research visits/downloads
agree to sign an off-campus property transfer form and return SCRAMx equipment

Exclusion criteria

serious, uncontrolled psychiatric illness
in recovery from pathological gambling
have an unstable address
intend to participate in activities incompatible with SCRAMx over the next 3 months
are wearing SCRAMx for legal purposes

Treatment and study plan

Prize Contingency Management for Alcohol Abstinence

Behavioral

The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors

Standard Care

Behavioral

Primary outcomes

longest duration of abstinence from alcohol

Time frame: three months

objective report of alcohol use as measured by SCRAMx device

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Important dates

Study start: 2014
Primary completion: 2019
Study completion: 2019
First posted: May 9, 2014
Registry last updated: Nov 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed